RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-4.3%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$4.4B
AUM Growth
+$4.4B
(-23%)
Cap. Flow
-$286M
Cap. Flow
% of AUM
-6.51%
Top 10 Holdings %
Top 10 Hldgs %
53.32%
Holding
82
New
7
Increased
5
Reduced
49
Closed
11
Top Buys
| 1 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
$247M |
| 2 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
$45.3M |
| 3 |
Entrada Therapeutics
TRDA
|
$33.5M |
| 4 |
Centene
CNC
|
$29.8M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$25.1M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$97.2M |
| 2 |
argenx
ARGX
|
$73.2M |
| 3 |
The Beauty Health Co
SKIN
|
$58M |
| 4 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$34M |
| 5 |
Celldex Therapeutics
CLDX
|
$33.9M |
Sector Composition
| 1 | Healthcare | 94.86% |
| 2 | Consumer Staples | 2.79% |
| 3 | Industrials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Senti Biosciences
SNTI
$37.9M
| – | – |
-1,924,900
| Closed | -$19.1M |
|
|
PROF
77
Profound Medical
PROF
$131M
| – | – |
-787,346
| Closed | -$11.5M |
|
78
Ovid Therapeutics
OVID
$94.6M
| – | – |
-40,674
| Closed | -$137K |
|
79
Lifestance Health
LFST
$2.14B
| – | – |
-1,222,408
| Closed | -$17.7M |
|
80
Aprea Therapeutics
APRE
$8.91M
| – | – |
-694,918
| Closed | -$3.55M |
|
|
SYRS
81
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| – | – |
-38,912
| Closed | -$174K |
|
|
AMED
82
DELISTED
Amedisys
AMED
| – | – |
-150,376
| Closed | -$22.4M |
|